Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,212,276 papers from all fields of science
Search
Sign In
Create Free Account
Maternal Serum Triple Test
Screening for ALPHA-FETOPROTEIN; HUMAN CHORIONIC GONADOTROPIN; and unconjugated ESTRIOL in a pregnant woman's sera.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Maternal Serum Screening Tests
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Factors that affect the decision to undergo amniocentesis in women with normal Down syndrome screening results: it is all about the age
J. Grinshpun-Cohen
,
T. Miron-Shatz
,
Liat Ries‐Levavi
,
E. Pras
Health Expectations
2015
Corpus ID: 3348739
Risk for foetal Down syndrome (DS) increases as maternal age increases. Non‐invasive screening (maternal serum triple test) for…
Expand
2015
2015
The limited effect of information on Israeli pregnant women at advanced maternal age who decide to undergo amniocentesis
J. Grinshpun-Cohen
,
T. Miron-Shatz
,
Michal Berkenstet
,
E. Pras
Israel Journal of Health Policy Research
2015
Corpus ID: 2836180
BackgroundA primary goal of amniocentesis is the detection of trisomy 21 (Down syndrome- DS) in the fetus. This procedure…
Expand
2011
2011
The reliability of maternal serum triple test in prenatal diagnosis of fetal chromosomal abnormalities of pregnant Turkish women.
O. Demirhan
,
A. Pazarbasi
,
+12 authors
N. Inandiklioğlu
Genetic Testing and Molecular Biomarkers
2011
Corpus ID: 21285062
AIM The purpose of this article was to evaluate the reliability of maternal serum triple marker screening of alpha-fetoprotein…
Expand
2010
2010
Effectiveness of crosstrimester test in selecting high‐risk pregnant women to undergo invasive prenatal diagnosis
P. Guanciali-Franchi
,
I. Iezzi
,
B. Matarrelli
,
E. Morizio
,
G. Calabrese
,
G. Palka
Prenatal Diagnosis
2010
Corpus ID: 44403426
The effectiveness of serologic and echographic non-invasive prenatal screening (IPS) in identifying pregnant women at increased…
Expand
2008
2008
De novo 7q deletion with a positive maternal serum triple test screening
I. Park
,
Y. S. Jo
,
J. Shin
,
I. Sung
,
Myungshin Kim
The journal of obstetrics and gynaecology…
2008
Corpus ID: 26583145
A 32‐year‐old woman at 17 weeks of gestation had a high possibility (1:82) of having a child with Down syndrome. Fetal chromosome…
Expand
Review
2007
Review
2007
Fetal nuchal translucency thickness.
I. Witters
,
J. Fryns
Genetic Counseling
2007
Corpus ID: 35238070
In the early 1990s Nicolaides introduced screening for trisomy 21 by fetal nuchal translucency thickness measurement with…
Expand
2004
2004
Positive maternal serum triple test screening in severe early onset hypophosphatasia
I. Witters
,
P. Moerman
,
E. Mornet
,
J. Fryns
Prenatal Diagnosis
2004
Corpus ID: 41838015
Hypophosphatasia is a rare heritable inborn error of metabolism characterized by a liver/bone/kidney alkaline phosphatase…
Expand
2002
2002
Physical and psychomotor development of 1799 children born after second trimester amniocentesis for maternal serum positive triple test screening and normal prenatal karyotype
I. Witters
,
P. Moerman
,
A. V. Van Assche
,
J. Fryns
Journal of Medical Genetics
2002
Corpus ID: 30513631
In a previous retrospective study on the physical and psychomotor development of 868 children born after positive maternal serum…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE